drug

fluoxetine

Fluoxetine
MeSH D005473
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Hannover Medical School
3 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

3
The Staged Treatment in Early Psychosis Study
NCT02751632Phase 3Completed
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
NCT02593734Phase 4Completed

KOLs & investigators

3
Patrick McGorry, MD, PhDKOL score 8
Helge Frieling, Prof., MDKOL score 5
Angela L Ofori-Atta, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Hannover Medical School
company
trial
The Staged Treatment in Early Psychosis Study
PHASE3
trial
Pharmacovigilance in Gerontopsychiatric Patients
PHASE3
trial
Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
PHASE4
trial
indication
Schizophrenia
indication
Depression
indication
Anxiety Disorder
indication
Psychosomatic Disorders
indication
KOL
Patrick McGorry, MD, PhD
KOL score 8
person
Helge Frieling, Prof., MD
KOL score 5
person
Angela L Ofori-Atta, PhD
KOL score —
person